• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预处理的间充质干细胞通过改善神经功能和抑制细胞凋亡减轻大鼠脑缺血再灌注损伤

Preconditioned MSCs Alleviate Cerebral Ischemia-Reperfusion Injury in Rats by Improving the Neurological Function and the Inhibition of Apoptosis.

作者信息

Zheng Jin, Mao Xueyu, Wang Delong, Xia Shiliang

机构信息

Department of Neurology, Tongde Hospital of Zhejiang Province, Hangzhou 310012, China.

Department of Neurology, Minhang Hospital, Fudan University, Shanghai 201199, China.

出版信息

Brain Sci. 2022 May 11;12(5):631. doi: 10.3390/brainsci12050631.

DOI:10.3390/brainsci12050631
PMID:35625017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9140028/
Abstract

Mesenchymal stem cells (MSCs) have great application prospects in the treatment of ischemic injury. However, their long-time cultivation before transplantation and poor survival after transplantation greatly limit the therapeutic effect and applications. This study aimed to investigate whether MSCs under the ischemic microenvironment could improve their survival and better alleviate cerebral ischemic injury. Firstly, we used ischemic brain tissue to culture MSCs and evaluated the functional changes of MSCs. Then a middle cerebral artery occlusion (MCAO) model was induced in rats, and the pretreated MSCs were injected via the tail vein. The adhesive removal test, rotarod test, modified neurological severity score, and pathological analyses were applied to assess the rats' neurological function. Then the expression of neuron and apoptosis related markers was detected. The results indicated that ischemic brain tissue pretreated MSCs promoted the proliferation and the release of the growth factors of MSCs. Meanwhile, in MCAO model rats, transplantation of pretreated MSCs enhanced the neurogenesis, attenuated behavioral changes, reduced infarct size, and inhibited apoptosis. The expression of B-cell lymphoma-2 (Bcl-2), brain-derived neurotrophic factor (BDNF), glial fibrillary acidic protein (GFAP), NF-L, and NeuN were increased, while BCL2-Associated X (Bax) and Caspase-3 decreased. Our results suggest that MSCs pretreatment with stroke brain tissue could be an effective strategy in treating cerebral ischemic injury.

摘要

间充质干细胞(MSCs)在缺血性损伤治疗中具有广阔的应用前景。然而,它们在移植前需要长时间培养,且移植后存活率低,这极大地限制了其治疗效果和应用。本研究旨在探讨在缺血微环境下的间充质干细胞是否能提高其存活率并更好地减轻脑缺血损伤。首先,我们用缺血脑组织培养间充质干细胞并评估其功能变化。然后在大鼠中诱导大脑中动脉闭塞(MCAO)模型,并通过尾静脉注射预处理的间充质干细胞。采用黏附去除试验、转棒试验、改良神经功能缺损评分和病理分析来评估大鼠的神经功能。然后检测神经元和凋亡相关标志物的表达。结果表明,经缺血脑组织预处理的间充质干细胞促进了间充质干细胞的增殖和生长因子的释放。同时,在MCAO模型大鼠中,移植预处理的间充质干细胞可增强神经发生、减轻行为变化、减小梗死面积并抑制细胞凋亡。B细胞淋巴瘤-2(Bcl-2)、脑源性神经营养因子(BDNF)、胶质纤维酸性蛋白(GFAP)、神经丝轻链(NF-L)和神经元核抗原(NeuN)的表达增加,而BCL2相关X蛋白(Bax)和半胱天冬酶-3(Caspase-3)减少。我们的结果表明,用中风脑组织预处理间充质干细胞可能是治疗脑缺血损伤的有效策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/083b24a81344/brainsci-12-00631-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/ce661da31811/brainsci-12-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/bf01c656251b/brainsci-12-00631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/bd9bd8a47410/brainsci-12-00631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/9020dd7069da/brainsci-12-00631-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/e0cf0847e83d/brainsci-12-00631-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/d95997843458/brainsci-12-00631-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/b419f7c9f4e6/brainsci-12-00631-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/083b24a81344/brainsci-12-00631-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/ce661da31811/brainsci-12-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/bf01c656251b/brainsci-12-00631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/bd9bd8a47410/brainsci-12-00631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/9020dd7069da/brainsci-12-00631-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/e0cf0847e83d/brainsci-12-00631-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/d95997843458/brainsci-12-00631-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/b419f7c9f4e6/brainsci-12-00631-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c05/9140028/083b24a81344/brainsci-12-00631-g008.jpg

相似文献

1
Preconditioned MSCs Alleviate Cerebral Ischemia-Reperfusion Injury in Rats by Improving the Neurological Function and the Inhibition of Apoptosis.预处理的间充质干细胞通过改善神经功能和抑制细胞凋亡减轻大鼠脑缺血再灌注损伤
Brain Sci. 2022 May 11;12(5):631. doi: 10.3390/brainsci12050631.
2
Salidroside-pretreated mesenchymal stem cells contribute to neuroprotection in cerebral ischemic injury in vitro and in vivo.红景天苷预处理的间充质干细胞促进脑缺血损伤的体内外神经保护。
J Mol Histol. 2021 Dec;52(6):1145-1154. doi: 10.1007/s10735-021-10022-0. Epub 2021 Sep 27.
3
SOD3 overexpression alleviates cerebral ischemia-reperfusion injury in rats.过表达 SOD3 可减轻大鼠脑缺血再灌注损伤。
Mol Genet Genomic Med. 2019 Oct;7(10):e00831. doi: 10.1002/mgg3.831. Epub 2019 Aug 28.
4
Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia.鞘内注射人脐带血间充质干细胞治疗脑缺血模型大鼠的疗效。
Stem Cell Res Ther. 2011 Sep 22;2(5):38. doi: 10.1186/scrt79.
5
Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAo.自体脂肪来源间充质干细胞经颈动脉内移植可显著改善 MCAo 大鼠的神经功能缺损。
J Mater Sci Mater Med. 2014 May;25(5):1357-66. doi: 10.1007/s10856-014-5157-9. Epub 2014 Jan 28.
6
Mailuoning oral liquid attenuates convalescent cerebral ischemia by inhibiting AMPK/mTOR-associated apoptosis and promoting CREB/BDNF-mediated neuroprotection.脉络宁口服液通过抑制 AMPK/mTOR 相关凋亡和促进 CREB/BDNF 介导的神经保护作用减轻恢复期脑缺血。
J Ethnopharmacol. 2023 Dec 5;317:116731. doi: 10.1016/j.jep.2023.116731. Epub 2023 Jun 3.
7
Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model.表达脑源性神经营养因子的间充质干细胞可增强缺血性中风模型中的内源性神经发生。
Biomed Res Int. 2014;2014:129145. doi: 10.1155/2014/129145. Epub 2014 Feb 5.
8
Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats.骨髓间充质干细胞经 Survivin 修饰后移植对大鼠实验性脑卒中的影响。
J Transl Med. 2011 Jul 6;9:105. doi: 10.1186/1479-5876-9-105.
9
Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.视黄酸预处理的脐带华通氏胶间充质干细胞联合三碘甲状腺原氨酸可改善大鼠缺血性脑损伤脑室下区神经营养因子的表达。
Metab Brain Dis. 2017 Feb;32(1):185-193. doi: 10.1007/s11011-016-9897-8. Epub 2016 Aug 22.
10
Neuroprotective Effect of Mesenchymal Stromal Cell-Derived Extracellular Vesicles Against Cerebral Ischemia-Reperfusion-Induced Neural Functional Injury: A Pivotal Role for AMPK and JAK2/STAT3/NF-κB Signaling Pathway Modulation.间充质基质细胞衍生的细胞外囊泡对脑缺血再灌注诱导的神经功能损伤的神经保护作用:AMPK和JAK2/STAT3/NF-κB信号通路调节的关键作用
Drug Des Devel Ther. 2020 Jul 20;14:2865-2876. doi: 10.2147/DDDT.S248892. eCollection 2020.

引用本文的文献

1
Bibliometric Analysis and Visualized Study of Research on Mesenchymal Stem Cells in Ischemic Stroke.缺血性脑卒中中骨髓间充质干细胞研究的文献计量分析与可视化研究
Stem Cell Rev Rep. 2025 Apr 21. doi: 10.1007/s12015-025-10878-9.
2
Secretome from hypoxic mesenchymal stem cells as a potential therapy for ischemic stroke: Investigations on and expression.缺氧间充质干细胞分泌组作为缺血性中风的潜在治疗方法:对[具体内容1]和[具体内容2]表达的研究
Narra J. 2024 Dec;4(3):e1181. doi: 10.52225/narra.v4i2.1181. Epub 2024 Dec 26.
3
Therapeutic Applications of Engineered Mesenchymal Stromal Cells for Enhanced Angiogenesis in Cardiac and Cerebral Ischemia.

本文引用的文献

1
Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway.三七皂苷R1通过BDNF/Akt/CREB通路促进神经发生改善脑缺血/再灌注损伤
Front Pharmacol. 2021 May 7;12:615998. doi: 10.3389/fphar.2021.615998. eCollection 2021.
2
Protection against acute cerebral ischemia/reperfusion injury by Leonuri Herba Total Alkali via modulation of BDNF-TrKB-PI3K/Akt signaling pathway in rats.益母草总碱通过调节 BDNF-TrKB-PI3K/Akt 信号通路对大鼠急性脑缺血再灌注损伤的保护作用。
Biomed Pharmacother. 2021 Jan;133:111021. doi: 10.1016/j.biopha.2020.111021. Epub 2020 Nov 20.
3
工程化间充质基质细胞在心脏和脑缺血中增强血管生成的治疗应用。
Stem Cell Rev Rep. 2024 Nov;20(8):2138-2154. doi: 10.1007/s12015-024-10787-3. Epub 2024 Sep 21.
4
An update on stem cell therapy for stroke patients: Where are we now?脑卒中患者的干细胞治疗进展:我们现在在哪里?
J Cereb Blood Flow Metab. 2024 Sep;44(9):1469-1479. doi: 10.1177/0271678X241227022. Epub 2024 Apr 19.
5
Stem cell-based ischemic stroke therapy: Novel modifications and clinical challenges.基于干细胞的缺血性中风治疗:新的改良与临床挑战。
Asian J Pharm Sci. 2024 Feb;19(1):100867. doi: 10.1016/j.ajps.2023.100867. Epub 2023 Nov 10.
6
Secretome as a Tool to Treat Neurological Conditions: Are We Ready?外泌体作为治疗神经系统疾病的工具:我们准备好了吗?
Int J Mol Sci. 2023 Nov 20;24(22):16544. doi: 10.3390/ijms242216544.
Olfactory Mucosa Mesenchymal Stem Cells Alleviate Cerebral Ischemia/Reperfusion Injury Golgi Apparatus Secretory Pathway Ca -ATPase Isoform1.
嗅黏膜间充质干细胞减轻脑缺血/再灌注损伤 高尔基体分泌途径钙 -ATP酶同工型1
Front Cell Dev Biol. 2020 Oct 30;8:586541. doi: 10.3389/fcell.2020.586541. eCollection 2020.
4
Mesenchymal stem cells-derived mitochondria transplantation mitigates I/R-induced injury, abolishes I/R-induced apoptosis, and restores motor function in acute ischemia stroke rat model.间充质干细胞衍生的线粒体移植减轻缺血再灌注诱导的损伤,消除缺血再灌注诱导的细胞凋亡,恢复急性缺血性脑卒中大鼠模型的运动功能。
Brain Res Bull. 2020 Dec;165:70-80. doi: 10.1016/j.brainresbull.2020.09.018. Epub 2020 Oct 1.
5
Astrocytic endothelin-1 overexpression promotes neural progenitor cells proliferation and differentiation into astrocytes via the Jak2/Stat3 pathway after stroke.星形胶质细胞内皮素-1 过表达通过 Jak2/Stat3 通路促进卒中后神经祖细胞增殖和分化为星形胶质细胞。
J Neuroinflammation. 2019 Nov 16;16(1):227. doi: 10.1186/s12974-019-1597-y.
6
Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives.血管内间充质干细胞治疗引起的血栓形成风险:现状与未来展望。
Cells. 2019 Sep 27;8(10):1160. doi: 10.3390/cells8101160.
7
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
8
Honokiol Attenuates Sepsis-Associated Acute Kidney Injury via the Inhibition of Oxidative Stress and Inflammation.和厚朴酚通过抑制氧化应激和炎症减轻脓毒症相关性急性肾损伤。
Inflammation. 2019 Jun;42(3):826-834. doi: 10.1007/s10753-018-0937-x.
9
LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.LincRNA-p21 通过低氧预处理促进间充质干细胞的迁移能力和存活。
Stem Cell Res Ther. 2018 Oct 25;9(1):280. doi: 10.1186/s13287-018-1031-x.
10
Impaired Neurofilament Integrity and Neuronal Morphology in Different Models of Focal Cerebral Ischemia and Human Stroke Tissue.局灶性脑缺血不同模型及人类中风组织中神经丝完整性和神经元形态受损。
Front Cell Neurosci. 2018 Jun 18;12:161. doi: 10.3389/fncel.2018.00161. eCollection 2018.